![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dichloroethane | increases expression | ISO | RGD:1557116 | 6480464 | ethylene dichloride results in increased expression of DPP9 mRNA | CTD | PMID:28960355 | 17beta-estradiol | affects expression | ISO | RGD:1350502 | 6480464 | Estradiol affects the expression of DPP9 mRNA | CTD | PMID:22574217 | 17beta-estradiol | increases expression | ISO | RGD:1350502 | 6480464 | Estradiol results in increased expression of DPP9 mRNA | CTD | PMID:31614463 | 17beta-estradiol | multiple interactions | ISO | RGD:1350502 | 6480464 | [Estradiol co-treated with TGFB1 protein] results in increased expression of DPP9 mRNA | CTD | PMID:30165855 | 2,2',4,4'-Tetrabromodiphenyl ether | decreases expression | ISO | RGD:1350502 | 6480464 | 2 more ... | CTD | PMID:31675489 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1557116 | 6480464 | Tetrachlorodibenzodioxin affects the expression of DPP9 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1557116 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of DPP9 mRNA | CTD | PMID:26290441, PMID:28922406 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1350502 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of DPP9 mRNA | CTD | PMID:22903824 | 2,4,6-tribromophenol | decreases expression | ISO | RGD:1350502 | 6480464 | 2 more ... | CTD | PMID:31675489 | 3,3',5,5'-tetrabromobisphenol A | decreases expression | ISO | RGD:1350502 | 6480464 | tetrabromobisphenol A results in decreased expression of DPP9 protein | CTD | PMID:31675489 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:1350502 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of DPP9 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of DPP9 mRNA | CTD | PMID:28628672 | 4,4'-sulfonyldiphenol | multiple interactions | ISO | RGD:1350502 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of DPP9 mRNA | CTD | PMID:28628672 | 4,4'-sulfonyldiphenol | increases methylation | ISO | RGD:1557116 | 6480464 | bis(4-hydroxyphenyl)sulfone results in increased methylation of DPP9 promoter | CTD | PMID:33297965 | 4,4'-sulfonyldiphenol | decreases expression | ISO | RGD:1350502 | 6480464 | bis(4-hydroxyphenyl)sulfone results in decreased expression of DPP9 mRNA | CTD | PMID:30616060 | acrolein | multiple interactions | ISO | RGD:1350502 | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of DPP9 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of DPP9 mRNA | CTD | PMID:32699268 | Aflatoxin B2 alpha | increases methylation | ISO | RGD:1350502 | 6480464 | aflatoxin B2 results in increased methylation of DPP9 intron | CTD | PMID:30157460 | alpha-pinene | multiple interactions | ISO | RGD:1350502 | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of DPP9 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of DPP9 mRNA | CTD | PMID:32699268 | aristolochic acid | increases expression | ISO | RGD:1350502 | 6480464 | aristolochic acid I results in increased expression of DPP9 mRNA, aristolochic acid I results in increased expression of DPP9 protein | CTD | PMID:33212167 | arsane | affects methylation | ISO | RGD:1350502 | 6480464 | Arsenic affects the methylation of DPP9 gene | CTD | PMID:25304211 | arsenic atom | affects methylation | ISO | RGD:1350502 | 6480464 | Arsenic affects the methylation of DPP9 gene | CTD | PMID:25304211 | arsenite(3-) | multiple interactions | ISO | RGD:1350502 | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to DPP9 mRNA] | CTD | PMID:32406909 | atrazine | decreases expression | ISO | RGD:1350502 | 6480464 | Atrazine results in decreased expression of DPP9 mRNA | CTD | PMID:22378314 | benzo[a]pyrene | increases mutagenesis | ISO | RGD:1350502 | 6480464 | Benzo(a)pyrene results in increased mutagenesis of DPP9 gene | CTD | PMID:25435355 | benzo[a]pyrene | affects methylation | ISO | RGD:1350502 | 6480464 | Benzo(a)pyrene affects the methylation of DPP9 intron | CTD | PMID:30157460 | benzo[a]pyrene | increases methylation | ISO | RGD:1350502 | 6480464 | Benzo(a)pyrene results in increased methylation of DPP9 promoter | CTD | PMID:27901495 | benzo[e]pyrene | increases methylation | ISO | RGD:1350502 | 6480464 | benzo(e)pyrene results in increased methylation of DPP9 intron | CTD | PMID:30157460 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of DPP9 mRNA | CTD | PMID:25181051 | bisphenol A | multiple interactions | ISO | RGD:1350502 | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of DPP9 gene | CTD | PMID:31601247 | bisphenol A | decreases expression | ISO | RGD:1350502 | 6480464 | bisphenol A results in decreased expression of DPP9 protein | CTD | PMID:31675489 | bisphenol A | increases expression | ISO | RGD:1557116 | 6480464 | bisphenol A results in increased expression of DPP9 mRNA | CTD | PMID:33221593 | bisphenol F | multiple interactions | ISO | RGD:1350502 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of DPP9 mRNA | CTD | PMID:28628672 | C60 fullerene | increases expression | EXP | | 6480464 | fullerene C60 results in increased expression of DPP9 mRNA | CTD | PMID:19167457 | cadmium dichloride | increases expression | ISO | RGD:1350502 | 6480464 | Cadmium Chloride results in increased expression of DPP9 mRNA | CTD | PMID:25596134 | carbon nanotube | increases expression | ISO | RGD:1557116 | 6480464 | Nanotubes more ... | CTD | PMID:25554681, PMID:25620056 | chloroacetaldehyde | increases expression | ISO | RGD:1350502 | 6480464 | chloroacetaldehyde results in increased expression of DPP9 mRNA | CTD | PMID:25596134 | cisplatin | increases expression | ISO | RGD:1350502 | 6480464 | Cisplatin results in increased expression of DPP9 mRNA | CTD | PMID:25596134 | cyclosporin A | increases expression | ISO | RGD:1350502 | 6480464 | Cyclosporine results in increased expression of DPP9 mRNA | CTD | PMID:25596134 | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of DPP9 mRNA | CTD | PMID:25596134 | daidzein | multiple interactions | ISO | RGD:1350502 | 6480464 | [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of DPP9 mRNA | CTD | PMID:27424125 | daidzein 7-O-beta-D-glucoside | multiple interactions | ISO | RGD:1350502 | 6480464 | [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of DPP9 mRNA | CTD | PMID:27424125 | decabromodiphenyl ether | decreases expression | ISO | RGD:1350502 | 6480464 | decabromobiphenyl ether results in decreased expression of DPP9 protein | CTD | PMID:31675489 | dexamethasone | multiple interactions | ISO | RGD:1350502 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of DPP9 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of DPP9 mRNA | CTD | PMID:28628672 | dicrotophos | increases expression | ISO | RGD:1350502 | 6480464 | dicrotophos results in increased expression of DPP9 mRNA | CTD | PMID:28302478 | dioxygen | increases expression | ISO | RGD:1350502 | 6480464 | Oxygen deficiency results in increased expression of DPP9 mRNA | CTD | PMID:25596134 | doxorubicin | decreases expression | ISO | RGD:1350502 | 6480464 | Doxorubicin results in decreased expression of DPP9 mRNA | CTD | PMID:29803840 | fenthion | increases expression | ISO | RGD:1557116 | 6480464 | Fenthion results in increased expression of DPP9 mRNA | CTD | PMID:34813904 | fulvestrant | multiple interactions | ISO | RGD:1350502 | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of DPP9 gene | CTD | PMID:31601247 | gallic acid | increases expression | ISO | RGD:1350502 | 6480464 | Gallic Acid results in increased expression of DPP9 mRNA | CTD | PMID:34408198 | genistein | multiple interactions | ISO | RGD:1350502 | 6480464 | [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of DPP9 mRNA | CTD | PMID:27424125 | genistein 7-O-beta-D-glucoside | multiple interactions | ISO | RGD:1350502 | 6480464 | [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of DPP9 mRNA | CTD | PMID:27424125 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of DPP9 mRNA | CTD | PMID:22061828 | glycitein | multiple interactions | ISO | RGD:1350502 | 6480464 | [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of DPP9 mRNA | CTD | PMID:27424125 | glycitin | multiple interactions | ISO | RGD:1350502 | 6480464 | [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of DPP9 mRNA | CTD | PMID:27424125 | ibuprofen | increases expression | ISO | RGD:1350502 | 6480464 | Ibuprofen results in increased expression of DPP9 mRNA | CTD | PMID:25596134 | ibuprofen | increases expression | EXP | | 6480464 | Ibuprofen results in increased expression of DPP9 mRNA | CTD | PMID:25596134 | indometacin | multiple interactions | ISO | RGD:1350502 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of DPP9 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of DPP9 mRNA | CTD | PMID:28628672 | ivermectin | decreases expression | ISO | RGD:1350502 | 6480464 | Ivermectin results in decreased expression of DPP9 protein | CTD | PMID:32959892 | metformin | decreases expression | EXP | | 6480464 | Metformin results in decreased expression of DPP9 mRNA | CTD | PMID:25596134 | methapyrilene | increases methylation | ISO | RGD:1350502 | 6480464 | Methapyrilene results in increased methylation of DPP9 intron | CTD | PMID:30157460 | methidathion | increases expression | ISO | RGD:1557116 | 6480464 | methidathion results in increased expression of DPP9 mRNA | CTD | PMID:34813904 | ozone | multiple interactions | ISO | RGD:1350502 | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of DPP9 mRNA more ... | CTD | PMID:32699268 | ozone | multiple interactions | ISO | RGD:1557116 | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of DPP9 mRNA, [Air Pollutants results in increased abundance of Ozone] which results in increased expression of DPP9 mRNA | CTD | PMID:34911549 | paracetamol | increases expression | ISO | RGD:1350502 | 6480464 | Acetaminophen results in increased expression of DPP9 mRNA | CTD | PMID:22230336 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of DPP9 mRNA | CTD | PMID:33387578 | pregnenolone 16alpha-carbonitrile | increases expression | ISO | RGD:1557116 | 6480464 | Pregnenolone Carbonitrile results in increased expression of DPP9 mRNA | CTD | PMID:28903501 | temozolomide | decreases expression | ISO | RGD:1350502 | 6480464 | Temozolomide results in decreased expression of DPP9 mRNA | CTD | PMID:31758290 | troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of DPP9 mRNA | CTD | PMID:25596134 | tungsten | decreases expression | ISO | RGD:1557116 | 6480464 | Tungsten results in decreased expression of DPP9 mRNA | CTD | PMID:30912803 | valproic acid | affects expression | ISO | RGD:1350502 | 6480464 | Valproic Acid affects the expression of DPP9 mRNA | CTD | PMID:25979313 | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of DPP9 mRNA | CTD | PMID:23034163 | zoledronic acid | increases expression | ISO | RGD:1350502 | 6480464 | zoledronic acid results in increased expression of DPP9 mRNA | CTD | PMID:20977926 | |